Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-30

FDA Approved: VENLAFAXINE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original application (ANDA) for venlafaxine from Zydus Lifesciences Limited, enabling generic access to the antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

ORIG AP for VENLAFAXINE (VENLAFAXINE)